. Author manuscript; available in PMC: 2021 Apr 1.

Published in final edited form as: Neurogastroenterol Motil. 2020 Jan 20;32(4):e13779. doi: 10.1111/nmo.13779

Table 3. Demographic features and characteristics of DM patients.

Characteristic	Normal, N (%) (n=152)	Rapid, N (%) (n=27)
Demographics and lifestyle
Women	107 (70%)	20 (74%)
Age, mean ± SD, year	50 ± 14	50 ± 15
BMI, mean ± SD, kg/m^a	28 ± 9	30 ± 10
Overweight	31 (20%)	6 (22%)
Obese	59 (55%)	14 (52%)
DM-related variables
Type 1 DM	55 (36%)	9 (33%)
Duration of Type 1 DM^a	21 ± 12	33 ± 17
Duration of Type 2 DM^a	12.1 ± 9.1	11.1 ± 9.01
HbA1c levels, mean ± SEM^a	7.6 ± 1.6	7.25 ± 1.8
Treatment of DM
No medication	8 (5%)	2 (7%)
Only insulin therapy^*	89 (59%)	9 (33%)
Only oral hypoglycemic agents (excluding GLP1 agonists, DPP IV inhibitors, pramlintide)	38 (25%)	11 (41%)
Only GLP1 agonists, DPP IV inhibitors, or pramlintide	11 (7%)	3 (11%)
More than one medication	6 (4%)	2 (8%)

P<0.05 for univariate associations among groups

Values for BMI, duration of DM and HbA1c were missing in 2, 32 and 23 patients respectively.